{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T03:19:24Z","timestamp":1764645564191},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"18","license":[{"start":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T00:00:00Z","timestamp":1620172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Purpose<\/jats:title>\n                  <jats:p>The case of a transgender female who developed gallstone pancreatitis in the context of estrogen use for gender-affirming hormone therapy is reported.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Summary<\/jats:title>\n                  <jats:p>A 24-year-old Caucasian transgender female presented to the emergency department for abdominal pain and vomiting after referral from urgent care for suspected pancreatitis. Her home medications included estradiol, medroxyprogesterone, and spironolactone for gender-affirming hormone therapy and omeprazole for reflux. The patient reported minimal alcohol intake, presented with mildly elevated triglyceride levels, and did not have a family history of pancreatitis or gallstone disease. She underwent a laparoscopic cholecystectomy on hospital day 4 and was given a postoperative diagnosis of chronic cholecystitis, cholelithiasis, and pancreatitis. Given her history and the present illness, the use of estrogen therapy is a likely risk factor for the development of gallstone pancreatitis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Estrogen is a cornerstone of gender-affirming hormone therapy used by transgender women; however, in addition to its role in gender identity confirmation, estrogen can result in drug-induced pancreatitis.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ajhp\/zxab190","type":"journal-article","created":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T14:12:44Z","timestamp":1620223964000},"page":"1674-1680","source":"Crossref","is-referenced-by-count":9,"title":["Estrogen-induced gallstone pancreatitis in a transgender female"],"prefix":"10.1093","volume":"78","author":[{"given":"Emily","family":"Freier","sequence":"first","affiliation":[{"name":"Drake University College of Pharmacy & Health Sciences, Des Moines, IA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn","family":"Kassel","sequence":"additional","affiliation":[{"name":"Drake University College of Pharmacy & Health Sciences, Des Moines, IA, and MercyOne West Des Moines, West Des Moines, IA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Rand","sequence":"additional","affiliation":[{"name":"MercyOne West Des Moines, West Des Moines, IA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhavana","family":"Chinnakotla","sequence":"additional","affiliation":[{"name":"University of Missouri Hospitals, Columbia, MO, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,5,5]]},"reference":[{"issue":"1","key":"2021090712270551400_CIT0001","doi-asserted-by":"crossref","first-page":"ITC1","DOI":"10.7326\/AITC201907020","article-title":"Care of the transgender patient","volume":"171","author":"Safer","year":"2019","journal-title":"Ann Intern Med"},{"issue":"4","key":"2021090712270551400_CIT0002","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/GRF.0000000000000396","article-title":"Gender-affirming hormone therapy for transgender females","volume":"61","author":"Randolph","year":"2018","journal-title":"Clin Obstet Gynecol"},{"key":"2021090712270551400_CIT0003","first-page":"73","article-title":"Low estrogen doses normalize testosterone and estradiol levels to the female range in transgender women","author":"Cunha","year":"2018","journal-title":"Clinics (Sao Paulo)"},{"issue":"4","key":"2021090712270551400_CIT0004","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S2213-8587(16)30319-9","article-title":"Oestrogen and anti-androgen therapy for transgender women","volume":"5","author":"Tangpricha","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"2021090712270551400_CIT0005","first-page":"353","article-title":"Estrogen-induced severe acute pancreatitis in a male","volume":"5","author":"Perego","year":"2004","journal-title":"JOP"},{"key":"2021090712270551400_CIT0006","doi-asserted-by":"crossref","DOI":"10.24150\/ajhm\/2018.023","article-title":"Estrogen-induced pancreatitis: transgender females at risk","author":"Goodwin","year":"2018","journal-title":"Am J Hosp Med."},{"key":"2021090712270551400_CIT0007","first-page":"2324709620921333","article-title":"A rare cause of acute pancreatitis in a transgender female","volume":"8","author":"Shipley","year":"2020","journal-title":"J Investig Med High Impact Case Rep"},{"issue":"1","key":"2021090712270551400_CIT0008","first-page":"45","article-title":"Drug-induced acute pancreatitis: a review","volume":"15","author":"Jones","year":"2015","journal-title":"Ochsner J"},{"issue":"5","key":"2021090712270551400_CIT0009","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1177\/2050640618755002","article-title":"Hypertriglyceridemic pancreatitis: epidemiology, pathophysiology and clinical management","volume":"6","author":"De Pretis","year":"2018","journal-title":"United European Gastroenterol J"},{"issue":"12","key":"2021090712270551400_CIT0010","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s11920-018-0973-0","article-title":"Gender-affirming hormone use in transgender individuals: impact on behavioral health and cognition","volume":"20","author":"Nguyen","year":"2018","journal-title":"Curr Psychiatry Rep."},{"key":"2021090712270551400_CIT0011","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s10354-006-0346-x","article-title":"Gender and gallstone disease","volume":"156","author":"Novacek","year":"2006","journal-title":"Wien Med Wochenschr."},{"issue":"12","key":"2021090712270551400_CIT0012","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s40264-013-0118-7","article-title":"Postmenopausal estrogen therapy and risk of gallstone disease: a population-based case-control study","volume":"36","author":"Simonsen","year":"2013","journal-title":"Drug Saf"},{"issue":"9","key":"2021090712270551400_CIT0013","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJM199202273260902","article-title":"Biliary sludge as a cause of acute pancreatitis","volume":"326","author":"Lee","year":"1992","journal-title":"N Engl J Med"},{"issue":"12","key":"2021090712270551400_CIT0014","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.3748\/wjg.15.1427","article-title":"Acute pancreatitis: etiology and common pathogenesis","volume":"15","author":"Wang","year":"2009","journal-title":"World J Gastroenterol"},{"issue":"1","key":"2021090712270551400_CIT0015","first-page":"99","article-title":"Estrogen-related pancreatitis in the setting of normal plasma lipids: case report","volume":"10","author":"Blake","year":"2003","journal-title":"Menopause"},{"issue":"6","key":"2021090712270551400_CIT0016","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1210\/jc.2004-0535","article-title":"Medical consequences of obesity","volume":"89","author":"Bray","year":"2004","journal-title":"J Clin Endocinol Metab."},{"issue":"4","key":"2021090712270551400_CIT0017","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.bpg.2014.07.013","article-title":"Obesity and the risk and prognosis of gallstone disease and pancreatitis","volume":"28","author":"Bonfrate","year":"2014","journal-title":"Best Pract Res Clin Gastroenterol."},{"issue":"5","key":"2021090712270551400_CIT0018","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/MOG.0000000000000386","article-title":"Obesity and pancreatitis","volume":"33","author":"Khatua","year":"2017","journal-title":"Curr Opin Gastroenterol."},{"key":"2021090712270551400_CIT0019","doi-asserted-by":"crossref","first-page":"16024","DOI":"10.1038\/nrdp.2016.24","article-title":"Gallstones","volume":"2","author":"Lammert","year":"2016","journal-title":"Nat Rev Dis Primers."},{"issue":"4","key":"2021090712270551400_CIT0020","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.gtc.2016.07.010","article-title":"The impact of obesity on gallstone disease, acute pancreatitis, and pancreatic cancer","volume":"45","author":"Cruz-Monserrate","year":"2016","journal-title":"Gastroenterol Clin North Am."},{"issue":"11","key":"2021090712270551400_CIT0021","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1210\/jc.2017-01658","article-title":"Endocrine treatment of gender-dysphoric\/gender-incongruent persons: an Endocrine Society clinical practice guideline","volume":"102","author":"Hembree","year":"2017","journal-title":"J Clin Endocrinol Metab."},{"key":"2021090712270551400_CIT0022","volume-title":"Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People.","author":"UCSF Transgender Care, Department of Family and Community Medicine, University of California San Francisco","year":"2016","edition":"2nd ed"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/advance-article-pdf\/doi\/10.1093\/ajhp\/zxab190\/37806863\/zxab190.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/78\/18\/1674\/40322767\/zxab190.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/78\/18\/1674\/40322767\/zxab190.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,7]],"date-time":"2021-09-07T12:28:36Z","timestamp":1631017716000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/78\/18\/1674\/6264946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,5]]},"references-count":22,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2021,5,5]]},"published-print":{"date-parts":[[2021,9,7]]}},"URL":"https:\/\/doi.org\/10.1093\/ajhp\/zxab190","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,9,15]]},"published":{"date-parts":[[2021,5,5]]}}}